Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
73.01%
Operating Margin
39.98%
Net Margin
35.14%
Efficiency Metrics
Revenue per Expense Ratio
1.66
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
69.97%
Income Tax Rate
0.00%
EPS
4.4300000000
Balance Sheet Analysis
Current Ratio
0.80
Cash Ratio
0.24
Working Capital
$-32.90M
Debt to Equity
0.65
Debt to Assets
37.54%
Equity Ratio
57.72%
Cash Flow Analysis
Operating Cash Flow Ratio
59.27%
Free Cash Flow Ratio
50.31%
CapEx to Revenue
8.96%
Dividends Paid
$225.63M
Stock Buybacks
No buybacks
Total Shareholder Returns
$225.63M
Cash Position Change
71,798.2%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 9.59%
Detailed Growth Metrics
Core Performance
Revenue
17.16%
Net Income
7.69%
EPS
1.37%
Operating Income
24.14%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
2.55%
Operating Cash Flow
6.86%
Free Cash Flow
22.69%
Balance Sheet Health
Assets
11.98%
Debt
-9.94%
Book Value per Share
25.79%
Inventory
100.00%
Shareholder Returns
Dividends per Share
9.59%
Shares Outstanding
6.16%
Long Term Trends
3Y Revenue/Share
36.19%
5Y Revenue/Share
48.85%
3Y Dividend/Share
63.23%
5Y Dividend/Share
148.00%